Commentary | Published:

Immunology research: challenges and opportunities in a time of budgetary constraint

Nature Immunology volume 8, pages 114117 (2007) | Download Citation

There have been enormous advances in the field of immunology over the past 3 decades, and those advances have had a positive effect on many subspecialties of medicine. Opportunities for even more notable advances remain. However, present and projected budget constraints for the National Institutes of Health have created formidable challenges. This commentary addresses the opportunities and challenges for the field of immunology during a period of restricted budgets.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Science 312, 499 (2006).

  2. 2.

    International Human Genome Sequencing. C. Nature 431, 931–945 (2004).

  3. 3.

    et al. Annu. Rev. Immunol. 24, 353–389 (2006).

  4. 4.

    & Mol. Cell 22, 561–569 (2006).

  5. 5.

    , , & Immunobiology: The Immune System in Health and Disease 6th edn. 135–165 (Garland Science Publishing, New York, 2005).

  6. 6.

    , , , & J. Gen. Virol. 87, 29–38 (2006).

  7. 7.

    et al. Eur. J. Immunol. 9, 205–210 (1979).

  8. 8.

    et al. Nature 372, 691–694 (1994).

  9. 9.

    & Proc. R. Soc. Lond. B 147, 258–267 (1957).

  10. 10.

    et al. Proc. Natl. Acad. Sci. USA 103, 8459–8464 (2006).

  11. 11.

    et al. Science 314, 935–936 (2006).

  12. 12.

    et al. Science 314, 997–1001 (2006).

  13. 13.

    Cold Spring Harb. Symp. Quant. Biol. 54, 1–13 (1989).

  14. 14.

    Vaccine 22, 3658–3668 (2004).

  15. 15.

    & Cell 124, 849–863 (2006).

  16. 16.

    et al. Immunity 23, 227–239 (2005).

  17. 17.

    & Nat. Immunol. 6, 331–337 (2005).

  18. 18.

    et al. Science 312, 1355–1359 (2006).

  19. 19.

    & Annu. Rev. Immunol. 24, 681–704 (2006).

  20. 20.

    , , , & Eur. J. Immunol. 36, 267–277 (2006).

  21. 21.

    et al. Nat. Immunol. 7, 868–874 (2006).

  22. 22.

    , , , & Cell 118, 229–241 (2004).

  23. 23.

    , , & Cell 122, 107–118 (2005).

  24. 24.

    , & Semin. Immunol. 18, 297–304 (2006).

  25. 25.

    & Eur. J. Immunol. 36, 810–816 (2006).

  26. 26.

    Wall Street Journal A11 (1 September 2006).

  27. 27.

    The New York Times Section 3, p.3 (3 September 2006).

  28. 28.

    Lancet 348, 1002–1003 (1996).

Download references

Acknowledgements

We thank M. Johnson of the NIAID Office of Financial Management for budgetary numbers; T. Hauguel for data analysis and presentation; and J. McGowan, G. Folkers and N. Touchette for comments on the manuscript.

Author information

Affiliations

  1. Charles J. Hackett, Daniel Rotrosen, Hugh Auchincloss and Anthony S. Fauci are with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA. chackett@niaid.nih.gov

    • Charles J Hackett
    • , Daniel Rotrosen
    • , Hugh Auchincloss
    •  & Anthony S Fauci

Authors

  1. Search for Charles J Hackett in:

  2. Search for Daniel Rotrosen in:

  3. Search for Hugh Auchincloss in:

  4. Search for Anthony S Fauci in:

Competing interests

The authors declare no competing financial interests.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ni0207-114

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing